James Thaventhiran
MRC Laboratory of Molecular Biology(GB)University of Cambridge(GB)Cambridge University Hospitals NHS Foundation Trust(GB)Bridge University(SS)Io Therapeutics (United States)(US)MRC Toxicology Unit(GB)Medical Research Council(GB)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Immunodeficiency and Autoimmune Disorders, COVID-19 Clinical Research Studies, Immune Cell Function and Interaction, T-cell and B-cell Immunology
Most-Cited Works
- → Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity(2022)1,150 cited
- → SARS-CoV-2 evolution during treatment of chronic infection(2021)1,069 cited
- → Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2(2021)803 cited
- → Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies(2021)712 cited
- → Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease(2021)352 cited
- → CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response(2020)247 cited